YHB Investment Advisors Inc. Buys 2,105 Shares of UnitedHealth Group Inc (UNH)

YHB Investment Advisors Inc. grew its stake in UnitedHealth Group Inc (NYSE:UNH) by 5.7% in the third quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 39,206 shares of the healthcare conglomerate’s stock after acquiring an additional 2,105 shares during the quarter. UnitedHealth Group comprises approximately 1.6% of YHB Investment Advisors Inc.’s investment portfolio, making the stock its 16th biggest position. YHB Investment Advisors Inc.’s holdings in UnitedHealth Group were worth $10,430,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds also recently modified their holdings of UNH. Argent Trust Co increased its position in shares of UnitedHealth Group by 8.3% during the 4th quarter. Argent Trust Co now owns 13,911 shares of the healthcare conglomerate’s stock worth $3,066,000 after purchasing an additional 1,061 shares during the last quarter. Principal Financial Group Inc. increased its position in shares of UnitedHealth Group by 6.5% during the 1st quarter. Principal Financial Group Inc. now owns 1,945,624 shares of the healthcare conglomerate’s stock worth $416,364,000 after purchasing an additional 119,386 shares during the last quarter. Dorsey Wright & Associates increased its position in shares of UnitedHealth Group by 7.5% during the 2nd quarter. Dorsey Wright & Associates now owns 20,125 shares of the healthcare conglomerate’s stock worth $4,937,000 after purchasing an additional 1,409 shares during the last quarter. Rockland Trust Co. acquired a new stake in shares of UnitedHealth Group during the 2nd quarter worth about $205,000. Finally, Clinton Group Inc. increased its position in shares of UnitedHealth Group by 97.3% during the 2nd quarter. Clinton Group Inc. now owns 2,433 shares of the healthcare conglomerate’s stock worth $597,000 after purchasing an additional 1,200 shares during the last quarter. 85.44% of the stock is owned by institutional investors and hedge funds.

Shares of UnitedHealth Group stock opened at $261.01 on Friday. UnitedHealth Group Inc has a 12 month low of $208.48 and a 12 month high of $272.81. The stock has a market cap of $251.22 billion, a P/E ratio of 21.43, a PEG ratio of 1.50 and a beta of 0.78. The company has a debt-to-equity ratio of 0.61, a current ratio of 0.69 and a quick ratio of 0.75.

UnitedHealth Group (NYSE:UNH) last announced its earnings results on Tuesday, October 16th. The healthcare conglomerate reported $3.41 EPS for the quarter, beating analysts’ consensus estimates of $3.30 by $0.11. The company had revenue of $56.56 billion during the quarter, compared to analysts’ expectations of $56.34 billion. UnitedHealth Group had a return on equity of 23.62% and a net margin of 5.71%. UnitedHealth Group’s revenue for the quarter was up 12.4% on a year-over-year basis. During the same period last year, the business posted $2.66 EPS. As a group, equities analysts expect that UnitedHealth Group Inc will post 12.81 EPS for the current fiscal year.

A number of analysts recently issued reports on UNH shares. Jefferies Financial Group raised their price objective on UnitedHealth Group from $270.00 to $311.00 and gave the stock a “buy” rating in a research report on Wednesday, October 3rd. Argus raised their price objective on UnitedHealth Group to $285.00 and gave the stock a “buy” rating in a research report on Thursday, October 18th. Morgan Stanley raised their price objective on UnitedHealth Group from $278.00 to $305.00 and gave the stock an “overweight” rating in a research report on Wednesday, September 5th. Zacks Investment Research downgraded UnitedHealth Group from a “buy” rating to a “hold” rating in a research report on Tuesday, September 18th. Finally, ValuEngine raised UnitedHealth Group from a “hold” rating to a “buy” rating in a research report on Tuesday, October 2nd. One research analyst has rated the stock with a hold rating, twenty-two have given a buy rating and one has issued a strong buy rating to the company. The stock currently has an average rating of “Buy” and a consensus price target of $289.41.

In other news, EVP D Ellen Wilson sold 15,393 shares of UnitedHealth Group stock in a transaction dated Friday, August 24th. The stock was sold at an average price of $264.29, for a total value of $4,068,215.97. Following the completion of the transaction, the executive vice president now owns 66,402 shares in the company, valued at approximately $17,549,384.58. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, CEO Steven H. Nelson sold 26,033 shares of UnitedHealth Group stock in a transaction dated Friday, September 7th. The shares were sold at an average price of $270.65, for a total value of $7,045,831.45. The disclosure for this sale can be found here. Insiders sold a total of 79,568 shares of company stock valued at $21,128,177 in the last quarter. Company insiders own 0.87% of the company’s stock.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.

Further Reading: What is the yield curve?

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply